Sensus Healthcare ROE 2014-2025 | SRTS
Current and historical return on equity (ROE) values for Sensus Healthcare (SRTS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Sensus Healthcare ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-06-30 | $0.00B | $0.05B | -1.86% |
| 2025-03-31 | $0.00B | $0.05B | 3.70% |
| 2024-12-31 | $0.01B | $0.06B | 13.08% |
| 2024-09-30 | $0.01B | $0.05B | 17.39% |
| 2024-06-30 | $0.01B | $0.05B | 14.14% |
| 2024-03-31 | $0.01B | $0.05B | 10.47% |
| 2023-12-31 | $0.00B | $0.05B | 2.15% |
| 2023-09-30 | $0.00B | $0.05B | 0.00% |
| 2023-06-30 | $0.00B | $0.05B | 6.42% |
| 2023-03-31 | $0.01B | $0.05B | 15.05% |
| 2022-12-31 | $0.03B | $0.05B | 54.95% |
| 2022-09-30 | $0.03B | $0.05B | 67.50% |
| 2022-06-30 | $0.03B | $0.05B | 74.63% |
| 2022-03-31 | $0.02B | $0.04B | 77.06% |
| 2021-12-31 | $0.00B | $0.03B | 18.39% |
| 2021-09-30 | $0.00B | $0.02B | 0.00% |
| 2021-06-30 | $0.00B | $0.02B | -9.88% |
| 2021-03-31 | $-0.01B | $0.02B | -24.10% |
| 2020-12-31 | $-0.01B | $0.02B | -36.36% |
| 2020-09-30 | $-0.01B | $0.02B | -33.68% |
| 2020-06-30 | $-0.01B | $0.02B | -27.45% |
| 2020-03-31 | $0.00B | $0.03B | -14.95% |
| 2019-12-31 | $0.00B | $0.03B | -7.34% |
| 2019-09-30 | $0.00B | $0.03B | -11.21% |
| 2019-06-30 | $0.00B | $0.03B | -7.55% |
| 2019-03-31 | $0.00B | $0.03B | -13.33% |
| 2018-12-31 | $0.00B | $0.03B | -10.81% |
| 2018-09-30 | $0.00B | $0.03B | -13.33% |
| 2018-06-30 | $0.00B | $0.01B | -26.09% |
| 2018-03-31 | $0.00B | $0.01B | -25.00% |
| 2017-12-31 | $0.00B | $0.01B | -31.37% |
| 2017-09-30 | $0.00B | $0.01B | -29.63% |
| 2017-06-30 | $0.00B | $0.01B | -21.05% |
| 2017-03-31 | $0.00B | $0.01B | -13.56% |
| 2016-12-31 | $0.00B | $0.02B | 0.00% |
| 2016-09-30 | $0.00B | $0.02B | 0.00% |
| 2016-06-30 | $0.00B | $0.02B | 0.00% |
| 2016-03-31 | $0.00B | $0.01B | 0.00% |
| 2015-12-31 | $0.00B | $0.01B | -66.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.076B | $0.042B |
| Sensus Healthcare, Inc. is a medical device company It specializes in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy. The company's portfolio of treatment devices consists of the SRT-100(TM) and SRT-100 Vision(TM). Sensus Healthcare, Inc. is headquartered in Boca Raton, Florida. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $220.924B | 26.25 |
| Intuitive Surgical (ISRG) | United States | $205.210B | 80.29 |
| IDEXX Laboratories (IDXX) | United States | $56.979B | 56.59 |
| Edwards Lifesciences (EW) | United States | $49.662B | 33.30 |
| Alcon (ALC) | Switzerland | $39.183B | 26.48 |
| IQVIA Holdings (IQV) | United States | $37.616B | 20.98 |
| Mettler-Toledo (MTD) | United States | $29.577B | 34.60 |
| STERIS (STE) | Ireland | $26.302B | 27.15 |
| DexCom (DXCM) | United States | $23.249B | 32.05 |
| Waters (WAT) | United States | $23.062B | 30.50 |
| Hologic (HOLX) | United States | $16.584B | 17.46 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.430B | 0.00 |
| Globus Medical (GMED) | United States | $11.441B | 23.80 |
| Penumbra (PEN) | United States | $10.977B | 77.21 |
| Masimo (MASI) | United States | $8.046B | 25.78 |
| Sysmex ADR (SSMXY) | Japan | $6.553B | 20.82 |
| Glaukos (GKOS) | United States | $5.319B | 0.00 |
| Teleflex (TFX) | United States | $4.927B | 7.85 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.344B | 38.11 |
| LivaNova (LIVN) | United Kingdom | $3.092B | 16.70 |
| Alphatec Holdings (ATEC) | United States | $3.082B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.436B | 11.43 |
| Artivion (AORT) | United States | $2.256B | 103.54 |
| Nihon Kohden (NHNKY) | Japan | $1.858B | 16.22 |
| Elekta AB (EKTAY) | Sweden | $1.739B | 16.85 |
| PROCEPT BioRobotics (PRCT) | United States | $1.719B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.240B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.225B | 0.00 |
| AxoGen (AXGN) | United States | $1.111B | 0.00 |
| IRadimed (IRMD) | United States | $1.099B | 52.38 |
| Pulse Biosciences (PLSE) | United States | $1.017B | 0.00 |
| OPKO Health (OPK) | United States | $1.013B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.942B | 5.10 |
| SiBone (SIBN) | United States | $0.781B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.604B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.549B | 31.93 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.546B | 10.89 |
| Pacific Biosciences Of California (PACB) | United States | $0.525B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.522B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.475B | 0.00 |
| NeuroPace (NPCE) | United States | $0.450B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.441B | 12.18 |
| OrthoPediatrics (KIDS) | United States | $0.426B | 0.00 |
| RxSight (RXST) | United States | $0.412B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.408B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.390B | 2.94 |
| Alpha Tau Medical (DRTS) | Israel | $0.337B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.303B | 50.53 |
| Spectral Diagnostics (EDTXF) | Canada | $0.298B | 0.00 |
| CVRx (CVRX) | United States | $0.250B | 0.00 |
| 908 Devices (MASS) | United States | $0.214B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.212B | 0.00 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.183B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.149B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.148B | 0.00 |
| Neuronetics (STIM) | United States | $0.148B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.134B | 0.00 |
| LENSAR (LNSR) | United States | $0.124B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.075B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.073B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Spectral AI (MDAI) | United States | $0.049B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.046B | 0.00 | |
| Precision Optics (POCI) | United States | $0.038B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.025B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.014B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.51 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |